We are live on ! Find out more
CMLFU

CM Life Sciences, Inc. Unit
CMLFU

Delisted

CMLFU was delisted on the 22nd of July, 2021.

Back to rankings

42 hedge funds and large institutions have $233M invested in CM Life Sciences, Inc. Unit in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 15 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% less funds holding

Funds holding: 58 → 42 (-16)

41% less capital invested

Capital invested by funds: $393M → $233M (-$160M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

60% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 25

60% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 15

Holders
42
Holders Change
-16
Holders Change %
-27.59%
% of All Funds
0.74%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
10
Increased
6
Reduced
15
Closed
25
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$2.48M
2
GS
Gagnon Securities
New York
+$1.84M
3
GA
Gagnon Advisors
New York
+$1.43M
4
JG
Jefferies Group
New York
+$674K
5
BCM
Bluefin Capital Management
New York
+$500K

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$22M
2
WMSA
Weiss Multi-Strategy Advisers
New York
-$21.9M
3
Millennium Management
Millennium Management
New York
-$21.4M
4
Blackstone Inc
Blackstone Inc
New York
-$16.5M
5
TCIM
TOMS Capital Investment Management
New York
-$10.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIMCA
51
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$5.24M -500,000 Closed
GL
52
Governors Lane
New York
– -$5.24M -500,000 Closed
OP
53
Omni Partners
United Kingdom
– -$4.73M -452,046 Closed
MIM
54
Monashee Investment Management
Massachusetts
– -$4.19M -400,000 Closed
RCM
55
Radcliffe Capital Management
Pennsylvania
– -$4.19M -400,000 Closed
GCL
56
Glazer Capital LLC
New York
– -$3.6M -344,000 Closed
SCM
57
Suvretta Capital Management
New York
– -$2.67M -254,713 Closed
CCM
58
Context Capital Management
California
– -$2.09M -200,000 Closed
Hudson Bay Capital Management
59
Hudson Bay Capital Management
Connecticut
– -$1.05M -100,000 Closed
KPF
60
K2 Principal Fund
Ontario, Canada
– -$1.05M -100,000 Closed
DAM
61
Deltec Asset Management
New York
– -$607K -57,972 Closed
OWP
62
Old Well Partners
North Carolina
– -$216K -20,600 Closed
DCM
63
Dupont Capital Management
Delaware
– -$215K -19,998 -100%
Walleye Trading
64
Walleye Trading
New York
– -$188K -18,000 Closed
VCM
65
Vivaldi Capital Management
Illinois
– -$131K -12,511 Closed
PAM
66
Panagora Asset Management
Massachusetts
– -$132K -12,278 -100%
HP
67
Hound Partners
New York
– -$52K -5,000 Closed
1 2
3

CMLFU Hedge Fund Activity: Q4 2020 in Review

42 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences, Inc. Unit (CMLFU) for Q4 2020, worth a combined $233M — down 41% from $393M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of CMLFU and 10 opened new positions — a net loss of 15 holders — while 15 trimmed existing stakes and 6 added.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $2.48M. The largest seller was Linden Advisors, exiting entirely with an estimated $22M sold.

  • 42 institutional investors held CM Life Sciences, Inc. Unit (CMLFU) as of Q4 2020, down from 58 in Q3 2020.
  • Funds reported $233M of CM Life Sciences, Inc. Unit stock for Q4 2020, down 41% quarter-over-quarter.
  • 10 funds opened new CM Life Sciences, Inc. Unit positions in Q4 2020 and 25 closed out, a net change of -15 holders.
  • The largest CM Life Sciences, Inc. Unit buyer in Q4 2020 was Goldman Sachs, an estimated $2.48M added.
  • The largest CM Life Sciences, Inc. Unit seller in Q4 2020 was Linden Advisors, an estimated $22M sold.

Based on aggregated 13F filings for Q4 2020.